Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

CBIZ Experiences Small Insider Trades

CBIZ insider tradesSteven Gerard, Chief Executive Officer of CBIZ, Inc. (NYSE:CBZ), purchased 159 shares of common stock this week at $7.41 per share. The acquisition brought his total holdings up to 911,923 shares, or approximately $6,848,541. Since Gerard’s purchase, CBIZ’s stock value has increased by 1.35% and is currently trading at 11.3 times its trailing earnings. Despite the recent rise in share price, the stock is still available at a 60% price discount relative to the industry average. Surprising however, is the fact that CBIZ is trading very near its 52-week high of $7.73 per share.


Gerard has been acquiring small amounts of common stock each month under the amended CBIZ 2007 Employee Stock Purchase Plan, which was approved by Shareholders at the 2011 Annual Meeting. Acquiring stock under this plan allows the Chief Executive Officer to pay 15% for the shares. Later this month, on October 23rd, the firm will be announcing third-quarter results, hosted by Gerard himself. The firm’s third quarter ended on September 30th.

Hedge fund bulls will be glad to see the CEO continues share purchases, even in spite of the small number. As the largest hedge fund shareholder, P2 Capital Partners owns 2,418,265 shares of common stock, or approximately $18,161,170 worth of stock. The CBIZ shares owned by P2 Capital Partners make up 2.6% of the hedge fund’s equity portfolio. Cardinal Capital is the other large hedge fund holding the firm’s stock, with 2,208,701 shares.

Disclosure: Pablo Erbar holds no position in any stocks mentioned

Recommended Reading:

Midstates Petroleum’s CEO is Bullish

Equal Energy Insider Buying is Worth Watching

First Financial Bancorp Director Makes a Buy

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!